Led by gains in Divi’s Labs, Sun Pharma, Cadila Healthcare, and Dr Reddy’s Laboratories, the Nifty Pharma pack was trading marginally higher in Wednesday’s trade, with most stocks hovering near their all-time high levels.
- Anthropic IPO at $1.5 Trillion: What It Means for Indian Stock Markets and AI Investors
- Ashoka Buildcon Loses Rs 846 Crore Saudi Arabia ContractΒ
- South Korea Becomes Fourth Country to Cross $1 Trillion in ExportsΒ
- Humyn Labs Raises $47 Million in Series A Funding
- ArMee Infotech Signs Rs 1,629 Cr Solar MoU With MSEDCL
Shares of Cipla hit a new all-time high of Rs 997 in Wednesday’s session, looking poised to enter the four digit-share club after the Drugs Controller General of India (DCGI) permitted the firm to import Moderna’s Covid Vaccine with emergency use authorization in India.
Stock Covered in the news
Live
